{"id":"W2930076345","doi":"10.1080/10428194.2019.1576872","title":"Blinatumomab versus chemotherapy in first salvage or in later salvage for B-cell precursor acute lymphoblastic leukemia","year":2019,"lang":"en","type":"article","venue":"Leukemia & lymphoma/Leukemia and lymphoma","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"Kite Pharma; Celgene; Regeneron Pharmaceuticals; Novartis; Servier; Amgen; Pfizer; Roche","keywords":"Blinatumomab; Salvage therapy; Medicine; Chemotherapy; Hematopoietic stem cell transplantation; Refractory (planetary science); Internal medicine; Lymphoblastic Leukemia; Oncology; Leukemia; Transplantation; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.001215362,0.00195077,0.00289289,0.001876865,0.0003503806,0.0003392599,0.001298764,0.001807259,0.0005263509],"category_scores_gemma":[0.0005436513,0.001715773,0.0006862862,0.002469448,0.0006438349,0.0009326355,0.000639525,0.000655286,0.0007100877],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.04778494,"about_ca_system_score_gemma":0.01578068,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0015251,"about_ca_topic_score_gemma":0.001112376,"domain_scores_codex":[0.9891147,0.0002716699,0.002318566,0.003082174,0.001681747,0.003531135],"domain_scores_gemma":[0.9928222,0.00290158,0.0006176015,0.002134958,0.0003542734,0.001169446],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.4278519,0.008039434,0.1471914,0.01732756,0.004599995,0.02185727,0.01747382,0.002579605,0.07185576,0.002453826,0.07422437,0.204545],"study_design_scores_gemma":[0.5275181,0.008806136,0.1931174,0.003300517,0.001064715,0.003002756,0.001613492,0.1441764,0.03720166,0.0005359253,0.07469242,0.004970432],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9836483,0.001201253,0.0001864056,0.0006274125,0.001291203,0.005245895,0.0002165342,0.0004306464,0.007152354],"genre_scores_gemma":[0.9766115,0.001765993,0.002638595,0.002208509,0.0006026291,0.001113551,0.0004061399,0.0006067203,0.01404636],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1995746,"threshold_uncertainty_score":0.9994886,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01245070309718884,"score_gpt":0.2686966968504686,"score_spread":0.2562459937532798,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}